Xinnate

Lund, Sweden · Founded 2019 · Privately Held (backing)

Developer of a biopharmaceutical platform intended to develop proprietary peptides for the prevention and treatment of wounds and topical applications. Xinnate is based in Lund, Sweden and was founded in 2019. Its last reported valuation was $38.8 million in Dec 2022. It has raised $16.1 million.

Last reported valuation
$38.8M
Oct 2026
Priced at
—
Total raised
$16.1M
Last round
—
What is Xinnate worth?
$38.8Mlast reported valuation · Oct 2026

Xinnate's last reported valuation, Dec 2022. Nothing priced has surfaced since.

Free account
More of Xinnate with a free account
  • ·Watch Xinnate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Xinnate funding history

No rounds on record

No funding rounds for Xinnate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Xinnate valuation

Xinnate's last reported valuation was $38.8 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.

How Xinnate's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Xinnate, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Xinnate

What is Xinnate worth?
Xinnate is valued at $38.8M as of Oct 2026. Xinnate's last reported valuation, Dec 2022. Nothing priced has surfaced since.
How much has Xinnate raised?
Xinnate has raised $16.1M in total funding across its recorded rounds.